The global Cancer Immunotherapy Market was valued at USD 153.3 billion in 2025 and is projected to grow from USD 166.4 billion in 2026 to USD 305.8 billion by 2033, registering a CAGR of 9.0% from 2026 to 2033. North America dominated the global market with the largest revenue share of 43.3% in 2025, primarily driven by the increasing prevalence of cancer, continuous innovation in...

The biopharmaceutical excipients market is on the brink of substantial expansion, projected to reach a remarkable USD 12.4 billion by 2035. This growth reflects an impressive compound annual growth rate (CAGR) of 5.09% from its anticipated 2024 value of USD 7.18 billion. As the demand for advanced drug formulations accelerates, particularly in North America, this sector is becoming increasingly...

The landscape of the Intravascular Optical Coherence Tomography (OCT) Imaging System Market is evolving rapidly, with pivotal players steering its course towards unprecedented heights. As the market size is predicted to transition from USD 0.67 billion in 2024 to USD 1.698 billion by 2035, the market share dynamics reveal significant insights into competitive positioning and strategic...